PsyRX CNS Bio-Tech Ltd (PSRX.TA)
Tel Aviv · ILA · Healthcare · Drug Manufacturers - Specialty & Generic
ILA 63.70 (+9.08%) as of
Key statistics
- Market cap
- 6.51M
- Dividend yield
- 0.00%
- 52-week range
- 0.80 – 200.00
- Profit margin
- 0.00%
- Volume
- 22.46k
About PsyRX CNS Bio-Tech Ltd
PsyRX CNS Bio-Tech Ltd, a pharmaceutical development company, develops proprietary ibogaine-based platform for neuropsychiatric disorders. It is developing a PSX-001 for major depressive disorder; and PSX-002 for PTSD and trauma-related disorders. PsyRX CNS Bio-Tech Ltd was formerly known as Cannabotech LTD. The company was founded in 2019 and is based in Tel Aviv-Yafo, Israel.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Headquarters
- Tel Aviv-Yafo, Israel
Financial statements (income statement, balance sheet, cash flow) and an interactive price chart are available on this page with JavaScript enabled.